Navigation Links
'Oncomodulin'- Path To Nerve Regeneration

Absence of nerve regeneration in injured nerve fibres in the mature central nervous system has always baffled scientists and researchers worldwide, //but researchers at Children’s Hospital Boston have discovered a naturally occurring growth factor Oncomodulin which could well be an answer to nerve damage diseases like glaucoma, tumors, trauma, spinal cord injury and even stroke.

Yuqin yin,MD, PhD and Larry Benowitz, PhD neuroscientists on the faculty of Harvard Medical School, have done studies on optic nerve, which connects retinal nerve cells to the brain,and is frequently used as a model in nerve regeneration studies.

In the studies on live rats with optic nerve injury on adding oncomodulin with other growth promoting factors the axon growth doubled. In another experiment oncomodulin was mixed with a sugar mannose and forskolin which helps the cell receptors to become sensitised to protein messengers and this combination was more potent than ciliary neurotrophic factor CNTF in the same conditions.

Oncomodulin has been known to scientists for more than two decades to be present in tumor cells and placenta before the pathbreaking discovery in the axons of the nerve cells in the eye.

The theory behind the discovery of oncomodulin is: On injury to the eye an inflammatory reaction occurred which stimulated macrophages which are immune cells to move into the axons and release an unidentified protein which causes nerve regeneration. But for oncomdulin to work it requires an agent which should increase cyclic AMP which initiates various cellular reactions and helps make the oncomodulin receptor available on the cell surface.

There is also a two pronged approach as put forth by Benowitz and postdoctoral fellow Dietmar Fischer, PhD in which natural inhibitors of axon growth are suppressed and growth factors are activated and thus this approach could give incredible results.

The use of oncomo
'"/>




Page: 1 2

Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Stimulator for Depression Though Not Effective Was Given Approval

Post Your Comments:
(Date:12/2/2009)... , American Red Cross also part of the ...,, WASHINGTON, Dec. 2 /PRNewswire-USNewswire/ -...ibuted more than $1 million this year to help fund...o: http://www.newscom.com/cgi-bin/prnh/20090108/R...0,000, was given to help Philippine communities af...
(Date:12/2/2009)... , NASHVILLE, Tenn., Dec. 2 Aeg...usiness development company, has appointed Pearson... of Aegis, executive management team, Talbert will...rketing staff as they focus on solutions to help h...ps and physician relationships. ,, To this newl...
(Date:12/2/2009)... , BELLEVUE, Wash., Dec. 2 /PRNewswire-..., a leading online retailer of health, beauty, vis... now shipping to customers in China, India, and Br... than 3.5 billion international customers can shop...products on http://international.drugstore.com w...
(Date:12/2/2009)...study suggests the gene could be linked to life sp...hDay News) -- Sperm genes may affect life span in ...y females tend to live longer than males, Japanese...ice created using two female genomes -- bi-materna... mice created from the normal combination of a mal...
(Date:12/2/2009)... taking it for macular degeneration is not advise...althDay News) -- Women who take low-dose aspirin t...as well. , A new study by Harvard University re...nefit for aspirin in preventing age-related macula... sharp, central vision. , "The data indicate th...
Breaking Medicine News(10 mins):Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2Health News:In Women, Aspirin Might Ward Off Eye Trouble 2
...Society of Hypertension, Inc. (ASH) today announce...pertension and related cardiovascular disease -- t...hance the level of education of allied health prof... intended target groups, it is designed to improve...
...were the first in the area to benefit , , PALO AL...70s, have become the first people in Allentown, Pe... form of radiotherapy for cancer. A 72-year-old ma...ospital used RapidArc(TM) radiotherapy and image-g...
...fast, Inc. (NYSE: MED ) announced today that it ...ial results for the period ended March 31, 2009 on... the market. The Company will hold a conference ca...-0782 or (201) 689-8567, or can listen via a live ...
...swire-Asia-FirstCall/ -- Genesis,Pharmaceuticals E...sis" or the,"Company"), a U.S. pharmaceutical comp...Republic of China, today announced that it began m...i Ke Ke Li (an,antipyretic and antitussive granule...
...s little evidence for transfusions improving healt...view and analysis of the medical literature by a p...ference on Transfusion and Outcomes (ICCTO) he...ng given to patients. The vast majority of studie...
... Corporation (Nasdaq: KNSY ), a leading medical ...ons and technologies for a wide range of medical p...d quarter and first nine months of fiscal year 200...DA of $9.2 million. , Operating margin of 37...
Other Medicine News:Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 3Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 4Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 2Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 3Health News:Medifast, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Wednesday, April 29, 2009 2Health News:Genesis Pharmaceuticals Announces the Launch of Three TCM Products 2Health News:Genesis Pharmaceuticals Announces the Launch of Three TCM Products 3Health News:Blood Transfusion and Outcomes 2Health News:Blood Transfusion and Outcomes 3Health News:Blood Transfusion and Outcomes 4Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 2Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 3Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 4Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 5Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 6Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 7Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 8Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 9Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 10Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 11Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 12Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 13Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 14Health News:Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results 15
(Date:12/1/2009)... , RARITAN, N.J., Dec. 1 Joh...evelopment, L.L.C. announced today that it has sub...od and Drug Administration (FDA) for tapentadol ex...al analgesic for the management of moderate to sev...der. ,, Chronic pain, defined as pain that per...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repor...eport is available in its catalogue: ,, Molecu...tp://www.reportlinker.com/p0164231/Molecular-Diagn...ar diagnostics market is being driven by several g...and easy-to-handle techniques, which combine optim...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Report...port is available in its catalogue: ,, The Fut... 2015, Competitive Benchmarking, Product Pipeline ....com/p0166817/The-Future-of-Oncology-Therapeutics-...g-Product-Pipeline-and-Deals-Analysis.html ,, ...
Breaking Medicine Technology:New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3IBM Scientists First to Image the Anatomy of a Molecule 4913 1IBM Scientists First to Image the Anatomy of a Molecule 4913 2IBM Scientists First to Image the Anatomy of a Molecule 4913 3IBM Scientists First to Image the Anatomy of a Molecule 4913 4IBM Scientists First to Image the Anatomy of a Molecule 4913 5Los Angeles Clinic 28laserandveinclinic com 29 Offers the Latest Laser Skin Rejuvenation Treatments 55581 1Los Angeles Clinic 28laserandveinclinic com 29 Offers the Latest Laser Skin Rejuvenation Treatments 55581 2Announcing 3A Millennium Place Transitional Downtown Living for Women With Eating Disorders 55578 1Announcing 3A Millennium Place Transitional Downtown Living for Women With Eating Disorders 55578 2
...3, 2007 - Neurogen,Corporation (Nasdaq: NRGN) toda...ase 2a clinical studies for NG2-73, the Company,s,...presented in two,sessions at the SLEEP 2007 Annual...eties (APSS) in Minneapolis, Minnesota. Two,Phase ...a patients,are currently being conducted by the Co...
...wire-FirstCall/ --,Pharmasset, Inc. , a clinical-s...ng, developing and commercializing novel,drugs to ...tific,data presentations about Clevudine and Raciv...g Resistance Workshop being held in St.,Michael, B...tions,are available in the "Events & Presentat...
Other Medicine Technology:Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 2Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 3Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 4Pharmasset Presents Clevudine and Racivir Data at the International,HIV Drug Resistance Workshop 5
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: